The promise of novel direct oral anticoagulants.


The standard effective treatment of venous and arterial thromboembolism includes unfractionated and low-molecular weight heparin as well as warfarin, which have major disadvantages. In recent years, new anticoagulants have been developed in an attempt to overcome the known limitations of established treatment and develop improved therapies. This chapter… (More)
DOI: 10.1016/j.beha.2012.06.004


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.